MedTech Manufacturers
Unlock the "Un-sterilisable" (Product Innovation)
Many next-generation devices—such as soft surgical robotics, bio-electronic implants, and 3D-printed polymers—remain trapped in the lab because they cannot survive the thermal shock of steam or the chemical toxicity of Ethylene Oxide.
Smarterile provides a gentle, low-temperature, AI-optimised sterilisation path, allowing you to bring previously "un-sterilisable" materials and complex electronics to market without compromising structural or functional integrity.
Accelerated Time-to-Market (Regulatory De-risking)
Navigating sterilisation validation is a significant hurdle in FDA 510(k) or UKCA/CE marking submissions.
By referencing our FDA Device Master File (MAF), you can bypass the need to conduct your own primary sterilisation validation studies. Our pre-validated, AI-driven data allows you to "plug and play" our sterilisation parameters into your regulatory technical file, saving months of testing and significant capital expenditure.
Reduced Total Cost of Ownership & Warranty Claims
Harsh sterilisation cycles are a leading cause of premature instrument failure and expensive warranty returns for OEMs.
Smarterile’s AI control loop terminates the cycle the millisecond sterility is achieved, preventing "over-processing." This preserves the aesthetic and mechanical quality of your devices for longer, reducing the rate of failure-under-warranty and increasing customer satisfaction with your hardware.
Competitive Differentiation via "Smart IFUs"
In a crowded market, the Instructions for Use (IFU) can be a competitive tool.
Listing Smarterile as your validated sterilisation method offers your customers (hospitals and clinics) a faster, safer, and more sustainable workflow than your competitors. This positions your product as part of a modern, "Green Hospital" ecosystem, specifically targeting the NHS Net Zero and Sustainable Healthcare agendas.
Joint Development & Market Lock-in
We offer Joint Development Agreements (JDAs) to embed Smarterile technology directly into your product lifecycle.
By co-validating our system during your R&D phase, we ensure that your device and our steriliser are perfectly synchronised. This creates a "system-level" solution that ensures your hardware is always processed correctly, securing the long-term reliability of your innovation in the field.
Pharmaceutical Companies
Exponentially Faster Throughput (Eliminating the VHP Bottleneck)
Currently, moving materials into sterile isolators using Vaporised Hydrogen Peroxide (VHP) airlocks is a major bottleneck, often taking 3-4 hours per decontamination cycle.
Smarterile can be integrated as a Rapid Transfer Port solution. Our AI-driven system sterilises the outer surfaces of reagent bags, vials, and syringes in under 15 minutes. This drastically reduces downtime, unlocking continuous manufacturing and exponentially increasing your daily batch yields.
Seamless OEM Integration for Next-Gen Isolators
We offer technology licensing of the "Smarterile Engine" to established manufacturers of pharmaceutical isolators and gloveboxes.
You can embed our technology directly into your existing cleanroom equipment lines. This allows you to bring a next-generation, high-speed "smart isolator" to market, offering your customers a massive competitive advantage in throughput.
Enabling Point-of-Care (POC) Manufacturing
The industry is shifting toward personalised medicine, requiring decentralised, small-batch manufacturing directly at the hospital bedside, where industrial sterilisation isn't feasible.
Smarterile’s compact, AI-controlled system provides a validated, "plug-and-play" sterilisation method that complies with the MHRA Point-of-Care framework. Partnering with us allows you to safely deploy your compounding and therapy-generation systems directly into clinical settings.
Hospitals & Healthcare Trusts
Rapid Turnaround & Eliminating Theatre Delays
Operating theatre delays cost the NHS approximately £24 per minute, often exacerbated by bottlenecks in the Central Sterile Services Department (CSSD).
Smarterile’s rapid, point-of-care processing enables intra-operative instrument turnaround. The AI-driven system automatically processes mixed loads without requiring manual sorting, drastically reducing cycle times and maximising expensive theatre utilisation.
Asset Preservation & CapEx Avoidance
Modern surgical tools (e.g., robotic instruments, flexible endoscopes, delicate optics) are highly sensitive to the thermal shock of steam autoclaves, leading to rapid degradation and expensive repairs.
Our gentle, low-temperature process extends the lifespan of your highest-value assets, significantly reducing annual repair and replacement budgets. Furthermore, our "Sterility-as-a-Service" model eliminates the need for large upfront capital expenditure, moving advanced sterilisation to a manageable, all-inclusive monthly operational expense (OpEx).
Superior Infection Control & Patient Safety
Complex instrument geometries (like narrow lumens and articulating joints) are notoriously difficult to sterilise using legacy methods, contributing to Surgical Site Infections (SSIs).
Smarterile’s AI-optimised process guarantees a standard Sterility Assurance Level across the most complex device architectures. This ensures robust, medical-grade sterility rather than mere high-level disinfection, directly reducing infection rates, improving patient outcomes, and lowering the burden of post-operative care.
Accelerating Net Zero & Sustainability Targets
Healthcare providers are under strict mandates to meet sustainability goals, such as the NHS Net Zero 2045 target, and to reduce hazardous waste.
Smarterile completely eliminates the need for toxic chemical consumables (like Ethylene Oxide and Hydrogen Peroxide), using only standard ambient gases. It consumes ~80% less energy than industrial steam autoclaves and enables the safe sterilisation and reuse of heat-sensitive single-use plastics, drastically reducing your hospital's carbon footprint and incineration costs.
Automated Compliance & Digital Traceability
Maintaining sterilisation records for regulatory audits is traditionally a manual, labour-intensive process prone to human error.
The system features integrated, cloud-based digital compliance logging. The AI continuously monitors and records the precise lethality parameters of every cycle, providing instant, audit-ready traceability for every instrument processed without adding administrative burden to your clinical staff.
Semiconductor & Microelectronics Manufacturers
Enabling the Bio-Electronics Boom (Implantables & Wearables)
The fastest-growing segment of microelectronics involves implantable sensors, neural interfaces, and "lab-on-a-chip" diagnostics. These devices must be terminally sterilised before human use, but traditional steam autoclaves melt their polymer substrates, and chemical gases (EtO) corrode delicate copper/gold interconnects.
Smarterile’s room-temperature, chemical-free process provides the only viable terminal sterilisation method for complex bio-electronics. Partnering with us allows you to guarantee that your medical-grade chips remain perfectly sterile and fully functional without compromising their delicate CMOS structures.
Damage-Free Cleaning & Descumming
Sterilisation is critical in semiconductor fabs for removing organic residues (photoresist descumming) and preparing surfaces for wire bonding.
Smarterile’s ultra-gentle, AI-modulated process can be adapted for precision surface cleaning. Our technology provides highly controlled organic removal, ensuring pristine bond pads and wafer surfaces without damaging fragile dielectrics or inducing damage.
Strict Preservation of Thermal Budgets
Advanced semiconductor packaging (e.g., 2.5D/3D ICs, flexible substrates, and sensitive underfills) operates under incredibly strict thermal budgets. Exposing these assemblies to high heat during backend processing or sterilisation causes warpage and failure.
Because Smarterile's process operates at fundamentally low temperatures, it has zero impact on your meticulously engineered thermal budgets. You can process fully packaged, heterogeneous integrated devices without risking substrate warpage, delamination, or solder joint stress.
AI-Driven Yield Optimisation (Precise Endpoint Control)
In semiconductor manufacturing, over-processing (such as over-etching or excessive ashing) directly destroys yield, costing thousands of dollars per wafer.
Smarterile’s core IP is our AI-driven "smart cycle" control loop. Rather than running a blind, timed process, our sensors monitor the exact spectral signature of the chamber and terminate the process the millisecond the target parameter (whether sterility or organic removal) is achieved. This eliminates over-processing, tightly controlling variance, and directly improving your backend yield.
Cleanroom-Ready & Sustainable
Fabs are under increasing pressure to reduce the use of toxic chemicals and hazardous greenhouse gases in their processing environments.
Smarterile utilises only standard, ambient gases and produces zero toxic byproducts. It is perfectly suited for integration into ISO-certified cleanrooms, providing a green, sustainable alternative to hazardous chemical processing steps.
Manufacturers of Biodegradable Products
Unlocking Bio-Polymers (Solving the Sterilisation Trap)
The biggest barrier to commercialising biodegradable medical devices (e.g., PLA-based plastics, bioresorbable implants) is that they cannot survive traditional sterilisation. They melt in the high heat of steam autoclaves and chemically degrade when exposed to harsh gases like Ethylene Oxide (EtO).
Smarterile’s ultra-gentle, low-temperature process prevents thermal deformation and structural degradation. Partnering with us provides the "missing link," allowing you to finally bring sensitive, next-generation bio-materials out of the lab and into the clinical market.
A 100% "Green" Product Lifecycle
It is a contradiction to manufacture an eco-friendly, biodegradable product only to sterilise it using EtO, a highly toxic, carcinogenic greenhouse gas.
Smarterile leaves zero toxic chemical residues. By adopting our technology as your validated sterilisation method, you ensure your product maintains a genuinely 100% sustainable lifecycle from manufacturing through to disposal, protecting your brand's green integrity.
Enabling the Circular Economy (From Single-Use to Reusable)
Many sustainable medical plastics are currently forced into single-use models because hospitals cannot safely re-sterilise them without causing material failure.
Our AI-optimised cycle is so gentle that it enables the safe, validated re-sterilisation of bio-plastics. This allows you to pivot your business model from producing "eco-friendly single-use" items to highly profitable "limited-reuse" circular assets, drastically lowering the cost-per-use for your customers.
Dominating NHS "Net Zero" Procurement
Healthcare systems, particularly the NHS with its Net Zero 2045 and "Design for Life" mandates, are aggressively prioritising suppliers with strong Environmental, Social, and Governance (ESG) credentials.
By offering a joint solution—your sustainable materials paired with our zero-emission, low-energy sterilisation, we create an unbeatable, fully compliant ESG proposition. This allows you to bypass legacy competitors and win lucrative public sector procurement contracts driven by sustainability targets.
